Now showing items 1-2 of 2

    • Molecular proteomic characterization of a pediatric medulloblastoma xenograft 

      Tsangaris G.T., Dimas K., Malamou A., Katsafadou A., Papathanasiou C., Stravopodis D.J., Vorgias C.E., Gazouli M., Anagnostopoulos A.K. (2017)
      Background/Aim: Medulloblastoma (MBL), an archetypal primitive neuroectodermal tumor of the cerebellum, is the most common pediatric central nervous system malignancy representing approximately 20% of all childhood brain ...
    • Novel diarylamides and diarylureas with N-substitution dependent activity against medulloblastoma 

      Lawson C., Ahmed Alta T.B., Moschou G., Skamnaki V., Solovou T.G.A., Topham C., Hayes J., Snape T.J. (2021)
      Medulloblastoma – highly aggressive and heterogeneous tumours of the cerebellum – account for 15–20% of all childhood brain tumours, and are the most common high-grade childhood embryonal tumour of the central nervous ...